Skip to main content
. 2019 Oct 10;145(12):1150–1157. doi: 10.1001/jamaoto.2019.2768

Table 1. Distribution of Characteristics and Their Association With Study Outcomes.

Factor All Participants (N = 376) Odds Ratio (95% CI)
30-d Severe Complication (n = 193 [51%]) 90-d Mortality (n = 30 [8%]) 90-d Functional Decline (n = 36 [11%])a
Preoperative Factors
Age, median (range), y 83 (80-98) 1.05 (0.99-1.11) 1.20 (1.12-1.28) 0.96 (0.84-1.10)
Sex, No. (%)
Male 253 (67.3) 1.01 (0.76-1.33) 1.67 (0.81-3.45) 0.71 (0.31-1.63)
Female 123 (32.7) 1 [Reference] 1 [Reference] 1 [Reference]
BMI, median (range) 24.9 (14.8-47.4) 0.95 (0.92-0.99) 0.96 (.92-1.00) 0.91 (0.88-0.95)
Prior head and neck RT, No. (%)
No 232 (61.7) 1 [Reference] 1 [Reference] 1 [Reference]
Yes 144 (38.3) 1.32 (0.82-2.12) 2.26 (0.87-5.87) 1.31 (0.54-3.17)
Smoking, No. (%)
No 169 (44.9) 1 [Reference] 1 [Reference] 1 [Reference]
Yes 207 (55.1) 1.03 (0.78-1.36) 0.80 (0.40-1.60) 1.00 (0.52-1.93)
ACE-27 score, No. (%)
0-1 (none to mild) 193 (51.3) 1 [Reference] 1 [Reference] 1 [Reference]
2-3 (moderate to severe) 183 (48.7) 1.83 (1.28-2.61) 3.16 (1.15-8.68) 0.84 (0.45-1.59)
Frailty, No. (%)
<0.25 (low) 243 (64.6) 1 [Reference] 1 [Reference] 1 [Reference]
≥0.25 (high) 133 (35.4) 1.66 (1.12-2.44) 2.64 (0.85-8.20) 1.55 (0.73-3.31)
ASA classification, No. (%)b
1-2 76 (20.2) 1 [Reference] 1 [Reference] 1 [Reference]
3-4 300 (79.8) 1.22 (0.59-2.53) 2.42 (0.88-6.71) 1.85 (0.60-5.72)
Weight loss ≥4.5 kg, No. (%) 110 (29.3) 1.06 (0.75-1.51) 1.55 (0.69-3.47) 1.65 (0.69-3.96)
Functional status at baseline, No. (%)
Independent 306 (81.4) 1 [Reference] 1 [Reference] 1 [Reference]
Dependent plus assisted living 70 (18.6) 1.54 (0.96-2.48) 0.47 (0.14-1.53) 1.70 (0.70-4.15)
Operative Factors
Tumor site, No. (%)
Scalp, facial skin, or parotid 131 (34.8) 1 [Reference] 1 [Reference] 1 [Reference]
Maxilla, oral cavity, or oropharynx 207 (55.1) 1.30 (0.79-2.14) 0.81 (0.31-2.11) 3.03 (1.59-5.78)
Larynx, hypopharynx, or esophagus 38 (10.1) 1.58 (0.93-2.69) 2.71 (0.86-8.57) 2.06 (0.52-8.16)
Flap type, No. (%)
Free 281 (74.7) 1 [Reference] 1 [Reference] 1 [Reference]
Pedicle 95 (25.3) 0.64 (0.37-1.11) 1.29 (0.60-2.78) 0.71 (0.28-1.78)
Bony reconstruction, No. (%)c
No 214 (76.2) 1 [Reference] 1 [Reference] 1 [Reference]
Yes 67 (23.8) 0.91 (0.49-1.67) 0.99 (0.42-2.35) 1.47 (0.63-3.43)
Duration of surgery, median (range), h 8.7 (1.5-20.8) 1.10 (1.2-1.19) 1.03 (0.92-1.20) 1.15 (1.00-1.33)
Additional operations, No. (%)
No 297 (79.0) 1 [Reference] 1 [Reference] 1 [Reference]
Yes 79 (21.0) 5.1 (2.93-8.72) 1.68 (0.78-3.60) 2.80 (1.79-4.40)
Flap failure, No. (%)
No 350 (93.1) 1 [Reference] 1 [Reference] 1 [Reference]
Partial plus total 26 (6.9) 2.75 (1.30-5.80) 3.08 (1.21-7.79) 1.47 (0.63-3.46)
LOS, median (range), d 8 (2-101) 1.15 (1.10-1.20) 1.04 (1.01-1.08) 1.08 (1.05-1.12)

Abbreviations: ACE-27, Adult Comorbidity Evaluation–27; ASA, American Society of Anesthesiologists; BMI, body mass index (calculated as weight in kilograms divided by square of height in meters); LOS, length of stay; RT, radiotherapy.

a

Includes 328 patients who were not dependent at baseline and were alive at 90 days.

b

Higher scores indicate worsening overall health.

c

Includes 281 patients with free flaps.